The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.

Authors:
  • ZHZhen-Yu He
    Zhen-Yu He
  • FLFeng-Yan Li
    Feng-Yan Li
  • JWJun-Jie Wang
    Jun-Jie Wang
  • JGJun Guo
    Jun Guo
  • QLQin Lin
    Qin Lin
  • XGXun-Xing Guan
    Xun-Xing Guan

Abstract
The role of postmastectomy radiotherapy (PMRT) in breast cancer patients with T1-T2 tumors and 1-3 positive axillary nodes is still uncertain. This study investigated the value of PMRT for these patients.